The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term safety and efficacy analysis of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (COU-AA-302).
Dana E. Rathkopf
Research Funding - Johnson & Johnson
Matthew R. Smith
Consultant or Advisory Role - Johnson & Johnson
Research Funding - Johnson & Johnson
Johann Sebastian De Bono
Employment or Leadership Position - The Institute of Cancer Research
Consultant or Advisory Role - Astellas Pharma; Johnson & Johnson; Medivation
Honoraria - Astellas Pharma; Johnson & Johnson; Medivation
Christopher Logothetis
Consultant or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Johnson & Johnson; Novartis; Pfizer
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Johnson & Johnson; Novartis; Pfizer
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Johnson & Johnson; Novartis; Pfizer
Neal Shore
No relevant relationships to disclose
Paul L. De Souza
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Karim Fizazi
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Peter Mulders
No relevant relationships to disclose
Paul N. Mainwaring
Consultant or Advisory Role - Janssen; Roche; Sanofi
Honoraria - Janssen; Roche; Sanofi
John D Hainsworth
No relevant relationships to disclose
Tomasz M. Beer
Research Funding - Cougar Biotechnology; Janssen Biotech
Scott A. North
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Yves Fradet
Honoraria - Janssen-Ortho
Research Funding - Janssen-Ortho
Thomas W. Griffin
Employment or Leadership Position - Johnson & Johnson
Stock Ownership - Johnson & Johnson
Youn Choi Park
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Thian San Kheoh
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Eric Jay Small
No relevant relationships to disclose
Howard I. Scher
Consultant or Advisory Role - Aragon Pharmaceuticals (U); Bristol-Myers Squibb; Celgene (U); Dendreon; Endo/Orion Pharmaceuticals; Exelixis (U); Foundation Medicine (U); Genentech; Janssen (U); Johnson & Johnson (U); Medivation (U); Millennium (U); Novartis; Ortho Biotech; Sanofi ; Senior Scientific; Takeda
Research Funding - Aragon Pharmaceuticals; Bristol-Myers Squibb; Exelixis; Janssen; Janssen Research & Development; Medivation
Arturo Molina
Employment or Leadership Position - Johnson & Johnson
Stock Ownership - Johnson & Johnson
Charles J. Ryan
Honoraria - Janssen